Biohit corporation initiates arbitration proceedings concerning a breach of the license agreement

Read more

Biohit Oyj comments on the claims presented in public by a member of Biohit board of directors, Mr. Liu Feng

Read more

A study from Italy confirms: Low levels of G-17 biomarker of the GastroPanel® test predict the risk of esophagitis and esophageal reflux disease

Read more